Johnson & Johnson (NYSE:JNJ)

106.54
Data as of Sep 29
 -0.56 / -0.52%
Today’s Change
85.50
Today|||52-Week Range
108.77
+16.32%
Year-to-Date
Don't Underestimate Current Weakness
7:05am / TheStreet.com
Must-See Charts: 5 Big Stocks to Sidestep the Selloff
Sep 23 / TheStreet.com
Roche Releases Data from CLEOPATRA Study on Perjeta - Analyst Blog
Sep 29 / Zacks.com
Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog
Sep 22 / Zacks.com
Novartis Gives Updates on Signifor LAR and Secukinumab - Analyst Blog
Sep 29 / Zacks.com
Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog
Sep 22 / Zacks.com
Better Dividend Stock: Johnson & Johnson or Pfizer, Inc?
Sep 29 / MotleyFool.com
Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog
Sep 22 / Zacks.com
Allergan Writes Back, Coaxes Shareholders Against Valeant - Analyst Blog
Sep 26 / Zacks.com
Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog
Sep 22 / Zacks.com
Gilead's HIV Drugs Tybost and Vitekta Get FDA Clearance - Analyst Blog
Sep 26 / Zacks.com
Surprising Silver Lining for Gilead Sciences, inc. Stock
Sep 22 / MotleyFool.com
Nike Inc, 3M Co, Johnson & Johnson, PepsiCo, Inc.: The Stocks To Watch As Small-Caps ...
Sep 26 / Investing Channel
Is the Stock Market Ready to Plunge? Here Are 3 Things to Do Right Now
Sep 22 / MotleyFool.com
Roche Announces Positive Results from Studies on Avastin - Analyst Blog
Sep 26 / Zacks.com
Dividend Aristocrats: Time to Buy AbbVie Inc Stock?
Sep 19 / MotleyFool.com
Will Cintas (CTAS) Disappoint this Earnings Season? - Analyst Blog
Sep 26 / Zacks.com
Stock Market News for September 19, 2014 - Market News
Sep 19 / Zacks.com
Inovio/GeneOne Life Science Collaborate for Ebola Vaccine - Analyst Blog
Sep 25 / Zacks.com
3 Best Stocks to Invest in Pharma
Sep 19 / MotleyFool.com
Valeant (VRX) Sends Letter to Allergan, Provides Q3 Update - Analyst Blog
Sep 25 / Zacks.com
Gilead Sciences, inc. Stock's Incoming Game Changer
Sep 18 / MotleyFool.com
Why Organovo Holdings Inc Stock Crashed By 40% in 2014
Sep 25 / MotleyFool.com
Corporate bond ratings do not discern risk
Sep 18 / FT.com
#PreMarket Primer: Thursday, September 25: US Airstrikes Do Little To Stem ISIS Advan...
Sep 25 / Benzinga
AstraZeneca and Eli Lilly to unite for Alzheimer's drug challenge
Sep 16 / FT.com
Johnson & Johnson Hits New All-Time
Sep 24 / StockTwits
Apple or Exxon: Which is a better buy?
Sep 08 / CNNMoney.com
Allergan and Salix Pharmaceuticals Up on Takeover Rumors - Analyst Blog
Sep 24 / Zacks.com
Volunteers sought for human trials of Ebola vaccine
Sep 05 / FT.com
There's a 'death cross' in the stock market. Should you worry?
Sep 24 / CNNMoney.com
Heed L.L. Bean as swans gather
Sep 03 / FT.com
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Lower
Sep 23 / TheStreet.com
The U.S. dollar is super strong now
Sep 02 / CNNMoney.com
Baby GEs? General Electric may need a breakup
Sep 23 / CNNMoney.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.